Astonea Labs Limited is a pharmaceutical and cosmetic manufacturer with a wide product range including antibiotics, antihistamines, diabetes and cardiovascular drugs, gynecological products, analgesics, antifungals, and multivitamins. Their cosmetics cover skin, hair, and oral care in forms like creams, serums, and oils. They also trade in packaging and raw materials and offer contract manufacturing for domestic and international clients. Products are marketed under "Glow Up" and "Regero," with "Glow Up" sold on Amazon and Tata 1MG. A new skincare line, "Avicel," is launching soon. With exports to Iraq and Yemen, and a recent USFDA audit, Astonea is expanding into regulated markets.
Price Band₹128 - ₹135 |
Dates27 May - 29 May |
GMP₹1 (0.74%) |
Subscriptions- |
Issue Size₹37.67 Crs |
Price Band₹128 - ₹135 |
Listing AtBSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹37.67 Cr (0.28 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹37.67 Cr (0.28 Cr Shares) |
Face Value₹10 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
1,000
1,35,000
Maximum
1
1,000
1,35,000
|
|||
NII |
Minimum
2
2,000
2,70,000
|
The estimated Grey Market Premium of Astonea Labs IPO is ₹1 per share (0.74%)
Disclaimer: The GMP prices displayed here reflect news related to grey market trends. We do not trade or deal in the grey market, including subject-to-rates, nor do we recommend participating in grey market trading.
Particulars | Allocation |
---|---|
QIB | Not more than 50% of Net Offer |
NII | Not less than 15% of Net Offer |
Retail | Not less than 35% of Net Offer |
Market Maker | 1,44,000 EQ Shares |
Particulars | Dec-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Revenue from Operations | 69.55 | 80.19 | 67.05 | 30.06 |
Profit after Tax | 4.10 | 3.81 | 0.67 | 0.25 |
Net Worth | 17.28 | 11.97 | 8.16 | 7.49 |
Total Borrowing | 49.48 | 42.40 | 35.99 | 29.52 |
Total Assets | 96.52 | 80.89 | 64.28 | 52.91 |
NAV per share (in ₹) | 22.41 | 15.75 | 10.73 | 9.86 |
EPS - Basic (in ₹) | 5.32 | 5.01 | 0.88 | 0.33 |
The financial information presented is on a consolidated basis
KPI | KPI |
---|---|
EBITDA | 14.60% |
PAT | 4.75% |
ROE | 37.86% |
ROCE | 22.95% |
PE Ratio | 26.95 |
PB Ratio | 8.57 |
Mkt Cap (in Crs.) | 141.90 |
Particulars | Astonea Labs | Beta Drugs |
---|---|---|
Revenue from Ops (in Crs.) | 80.19 | 295.71 |
PAT (In Crs.) | 3.81 | 36.44 |
EPS - Basic | 5.01 | 37.90 |
NAV per share | 15.75 | 163.43 |
RONW | 31.83% | 23.19% |
EBITDA | 14.60% | 20.29% |
PAT Margin | 4.75% | 12.32% |
Price to earning (PE) | 26.95 | 49.00 |
Particulars | Astonea Labs |
---|---|
Revenue from Ops (in Crs.) | 80.19 |
PAT (In Crs.) | 3.81 |
EPS - Basic | 5.01 |
NAV per share | 15.75 |
RONW | 31.83% |
EBITDA | 14.60% |
PAT Margin | 4.75% |
Price to earning (PE) | 26.95 |
Beta Drugs |
---|
295.71 |
36.44 |
37.90 |
163.43 |
23.19% |
20.29% |
12.32% |
49.00 |
Name | Shareholding |
---|---|
Ashish Gulati | 96.40% |
Other Promoter | 2.02% |
Total | 98.42% |
Name | Designation |
---|---|
Ashish Gulati | Managing Director |
Sumit Kumar | CFO |
Name: Astonea Labs Limited
Address: SCO 186-187, 2nd Floor, Cabin No. 206, SECTOR 8 C, Sector 8, Chandigarh 160009, India
Number: +91 – 9888302323
Email: cs@astonea.org
Website: https://www.astonea.org/
Find answers to common questions that come in your mind related to IPO.
Astonea Labs IPO is a SME IPO having an issue size of Rs. ₹37.67 Crs. Astonea Labs IPO is priced at ₹128 - ₹135 per share. The issue opens on 27 May 25 and closes on 29 May 25.
Astonea Labs IPO opens on 27 May 25 and closes on 29 May 25.
The estimated Grey Market Premium of Astonea Labs IPO is ₹1 per share (0.74%).
The minimum lot size of Astonea Labs IPO is 1000 shares & the minimum application amount is Rs. 135000.
The allotment date of Astonea Labs IPO is 30 May 25.
The listing date of Astonea Labs IPO is 03 Jun 25.
Astonea Labs IPO is subscribed -.
Astonea Labs IPO is priced at ₹128 - ₹135 per share.
Click the allotment link on Astonea Labs IPO page of IPO360.